2025 A panel of plasma proteins associated with venous thromboembolism in patients with prostate cancer. Asha Jose†, Simon Lu†, Chao Zhang, Jennifer La, Melissa Young, J. Michael Gaziano, Nathanael R. Fillmore, Katya Ravid‡, Vipul C. Chitalia‡† Equal first authorship · ‡ Equal senior authorship Cancer Biomarkers42(12), 18758592251390251 Cancer-Associated Thrombosis Prostate Cancer Proteomic Profiling Biomarkers Risk Stratification
2025 Dietary tryptophan augments cancer-associated venous thrombogenicity mitigated by indoleamine 2,3-dioxygenase 1 inhibition. Saran Lotfollahzadeh†, Asha Jose†, Xiaosheng Yang, Tanvi Bathla, Adam Lazowski, Isaac Hoekstra, Kashvi Sethuraman, Sowmya Potluri, Karlynn N. Dulberger, Jennifer La, Nathanael R. Fillmore, Maria Del Carmen Piqueras, Norman Lee, Howard Cabral, Katya Ravid, Vipul C. Chitalia† Equal first authorship Blood Advances9(19), 4910-4923 Cancer-Associated Thrombosis Colon Cancer Cardio-Oncology Dietary Tryptophan Indoleamine 2,3-Dioxygenase 1 Inhibition
2025 External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital. Karlynn N. Dulberger†, Jennifer La†, Ang Li†, Saran Lotfollahzadeh, Asha Jose, Nhan V. Do, Mary T. Brophy, J. Michael Gaziano, Katya Ravid, Vipul C. Chitalia, Nathanael R. Fillmore† Equal first authorship Research and Practice in Thrombosis and Haemostasis9(1), 102650 Cancer-Associated Thrombosis External Validation Electronic Health Records Retrospective Cohort Study Cancer Patients
